![]() International Stem Cell Corporation International Stem Cell Corporation is a biotechnology company focused on therapeutic and research products. | ![]() C2N Diagnostics C2N Diagnostics is a company that develops and commercializes diagnostics for Alzheimer’s disease and related forms of neurodegeneration. | |||
Founding Date | Founding Date 2021 | Founding Date 2001 | Founding Date 2007 | Founding Date 2002 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Irvine, US HQ Los Angeles, US | Locations Carlsbad, US HQ Frederick, US Oceanside, US | Locations St. Louis, US HQ | Locations HQ |
Employees | Employees N/A | Employees 3919% decrease | Employees 96 | Employees N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $9.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₩56.2b (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods $4m (FY, 2025) | Cost of goods N/A | Cost of goods ₩38.4b (FY, 2023) |
Gross profit | Gross profit N/A | Gross profit $5.1m (FY, 2025) | Gross profit N/A | Gross profit ₩22.6b (FY, 2023) |
Net income | Net income N/A | Net income ($418k) (FY, 2025) | Net income N/A | Net income ₩3.6b (FY, 2023) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 7.5m | Total funding raised $ 20m | Total funding raised N/A |

International Stem Cell Corporation is a biotechnology company focused on therapeutic and research products.
View company
C2N Diagnostics is a company that develops and commercializes diagnostics for Alzheimer’s disease and related forms of neurodegeneration.
View company